Display options
Cite
Bashshur ZF, Terro AM, Haibi CP, et al. Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors. Clin Ophthalmol. 2008;2(2):269-74doi: 10.2147/opth.s1674.
Bashshur, Z. F., Terro, A. M., Haibi, C. P., Halawi, A. M., Schakal, A., & Noureddin, B. N. (2008). Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors. Clinical ophthalmology (Auckland, N.Z.), 2(2), 269-74. https://doi.org/10.2147/opth.s1674
Bashshur, Ziad F, et al. "Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors." Clinical ophthalmology (Auckland, N.Z.) vol. 2,2 (2008): 269-74. doi: https://doi.org/10.2147/opth.s1674
Bashshur ZF, Terro AM, Haibi CP, Halawi AM, Schakal A, Noureddin BN. Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors. Clin Ophthalmol. 2008 Jun;2(2):269-74. doi: 10.2147/opth.s1674. PMID: 19668715; PMCID: PMC2693970.
Copy Download .nbib Format: NLM
Share it on

Clin Ophthalmol. 2008 Jun;2(2):269-74. doi: 10.2147/opth.s1674.

Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.

Clinical ophthalmology (Auckland, N.Z.)

Ziad F Bashshur, Abdallah M Terro, Christelle P El Haibi, Akaber M Halawi, Alexandre Schakal, Baha' N Noureddin

Affiliations

  1. The Department of Ophthalmology, American University of Beirut, Lebanon.

PMID: 19668715 PMCID: PMC2693970 DOI: 10.2147/opth.s1674

Abstract

PURPOSE: To determine the pattern of increase in intraocular pressure (IOP) following intravitreal triamcinolone acetonide (IVTA) and identify possible risk factors associated with this rise in IOP.

METHODS: We carried out a retrospective review of records for 185 patients (226 eyes) who received 4 mg of IVTA at the American University of Beirut Medical Center and Hotel Dieu de France eye clinics between 2003 and 2005

RESULTS: Mean follow-up was 8.17 months (range 6 to 24 months). The mean number of IVTA injections per eye was 1.31 +/- 0.69. The mean IOP increased after the first IVTA injection from 15.04 +/- 3.18 mmHg at baseline to a mean maximum of 17.20 +/- 5.75 mmHg (p < 0.0001, paired t-test) at month 3 of follow-up with a return to mean baseline IOP (15.49 +/- 4.79 mmHg) at month 12. Fifty nine of 226 eyes showed IOP higher than 21 mmHg during follow-up. Nine eyes started to have IOP greater than 21 mmHg, 6 to 12 months after a single injection. Intraocular pressure lowering medications were started when IOP exceeded 25 mmHg in 15 of the 226 eyes studied. No risk factors have been found to predict this IOP rise

CONCLUSIONS: IOP elevation can occur in a significant number of eyes receiving 4 mg of IVTA. This phenomenon seems to be transient and a small number of eyes required treatment during this period. Eyes that received IVTA need to be monitored for IOP changes especially during the first 3 months, but the IOP may still rise 6 months and even 12 months after a single injection. This study did not show any risk factor that may predict this IOP rise.

Keywords: Branch retinal vein occlusion; Uveitis; central retinal vein occlusion; choroidal neovascular membrane due to age-related macular degeneration; diabetic macular edema; intraocular pressure elevation; intravitreal triamcinolone acetonide

References

  1. Can J Ophthalmol. 2005 Feb;40(1):63-8 - PubMed
  2. Arch Ophthalmol. 2003 Feb;121(2):271-3 - PubMed
  3. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1440-4 - PubMed
  4. Arch Ophthalmol. 2003 May;121(5):729-30 - PubMed
  5. Br J Ophthalmol. 2003 Mar;87(3):361 - PubMed
  6. Ophthalmology. 2003 Apr;110(4):681-6 - PubMed
  7. Acta Ophthalmol Scand. 2003 Aug;81(4):399-401 - PubMed
  8. Br J Ophthalmol. 2002 Dec;86(12):1450-1 - PubMed
  9. Arch Ophthalmol. 2003 Nov;121(11):1663-4 - PubMed
  10. Ophthalmology. 2001 Apr;108(4):765-72 - PubMed
  11. Am J Ophthalmol. 2004 Mar;137(3):560-2 - PubMed
  12. Am J Ophthalmol. 2004 Nov;138(5):740-3 - PubMed
  13. Am J Ophthalmol. 2001 Apr;131(4):468-71 - PubMed
  14. Br J Ophthalmol. 2002 Sep;86(9):1066 - PubMed
  15. Arch Ophthalmol. 2001 Jun;119(6):897-8 - PubMed
  16. J Glaucoma. 2001 Aug;10(4):284-7 - PubMed
  17. Ophthalmology. 2003 Aug;110(8):1517-25 - PubMed
  18. Am J Ophthalmol. 2003 Aug;136(2):384-6 - PubMed
  19. Ophthalmology. 2005 Apr;112(4):593-8 - PubMed
  20. Aust N Z J Ophthalmol. 1999 Dec;27(6):431-2 - PubMed
  21. Ophthalmic Surg Lasers Imaging. 2003 Sep-Oct;34(5):386-90 - PubMed
  22. Arch Ophthalmol. 1963 Oct;70:492-9 - PubMed
  23. Arch Ophthalmol. 2003 May;121(5):667-73 - PubMed
  24. Exp Eye Res. 2005 Feb;80(2):249-58 - PubMed
  25. Ophthalmology. 2004 Feb;111(2):218-24; discussion 224-5 - PubMed

Publication Types